Michael A. Griffith has been appointed to serve on Repligen Corp.’s board of directors. Mr. Griffith currently serves as chief executive officer of Laureate Biopharmaceutical Services, Inc., a full-service contract manufacturing organization focused on the production and manufacture of biologic drugs. Mr. Griffith has extensive leadership experience in the bioprocessing and biopharmaceutical industries, as well as significant commercial and investment banking expertise. Mr. Griffith is the foun...